MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000–2006
Michael Z. David , Karen M. Rudolph, Thomas W. Hennessy, Diana L. Zychowski, Karthik Asthi, Susan Boyle-Vavra, and Robert S. Daum
Author affiliations: The University of Chicago, Chicago, Illinois, USA (M.Z. David, D.L. Zychowski, K. Asthi, S. Boyle-Vavra, R.S. Daum); Centers for Disease Control and Prevention, Anchorage, Alaska, USA (K.M. Rudolph, T.W. Hennessy)
Figure. Percentage of clonal complex (CC) 1, CC5, CC8, CC30, and other CC methicillin-resistant Staphylococcus aureus isolates from residents of the Anchorage region and the region of southwestern Alaska, USA, 2000–2003 and 2004–2006.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.